The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to ...

AstraZeneca was among the first multinational pharmaceutical firms to invest deeply in China's healthcare sector. Through ...

The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...

Eli Lilly and Novo Nordisk are expected to announce price reductions for their weight-loss drugs as part of the TrumpRx ...

In this instalment of the Budget Briefing the boss of Peel Hunt urges Reeves to prioritise economic nationalism.

Key market opportunities in the pharma 5 sector include leveraging digital health technologies, AI-driven drug discovery, and ...

The biggest risers on the FTSE 100 were Convatec, up 6.2 pence at 245p, Land Securities, up 12.5p at 627.5p, GSK, up 32.5p at ...

The FDA approved darolutamide for mHSPC on June 3, [2025], so we now have this in our armamentarium, along with all the other ...

Tempus AI has reached its long-awaited milestone of profitability, with positive earnings in the third quarter and ...

Eli Lilly and Novo Nordisk plan to announce new drug pricing deals with the White House, including for their weight loss ...